Benzinga's Top Pre-Market Losers

The Coca-Cola Company

shares fell 50.15% to $39.28 in the pre-market trading. Analysts at Goldman Sachs downgraded Coca-Cola from “conviction buy” to “neutral.” CenturyLink

dipped 3.69% to $41.20 in the pre-market session. CenturyLink's trailing-twelve-month ROE is 2.48%. J. C. Penney Company

moved down 2.56% to $22.80 in the pre-market session. Analysts at Piper Jaffray downgraded J. C. Penney from “overweight” to “neutral.” NPS Pharmaceuticals

dipped 2.51% to $7 in the pre-market session. The US Food and Drug Administration extended the action date for NPS Pharmaceuticals' New Drug Application (NDA) for Gattex® by three months to December 30, 2012.